Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pre-clinical evaluation of a potent and effective Pin1-degrading agent in pancreatic cancer

Molecular Therapy Oncology(2025)10.1016/j.omton.2025.201078Source: DataRank Database

Pre-clinical evaluation of a potent and effective Pin1-degrading agent in pancreatic cancer is a research paper published in Molecular Therapy Oncology (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.00)OA: goldTopics (14)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Tiane Li ORCID,A.M. PRENTISS,Parima Udompholkul,Fan Xia ORCID,Timothy W. Synold ORCID

Live enrichment

PubMed:41322199 PMC:PMC12657321 OpenAlex:https://openalex.org/W4415756485

National Cancer Institute

Grant: CA242620

National Cancer Institute

Grant: CA168517

National Cancer Institute

Grant: CA285114

National Institutes of Health

Grant: P41-GM103311

National Institutes of Health

Grant: NS107479

NCI NIH HHS

Grant: U54 CA285116

NCI NIH HHS

Grant: U54 CA285114

FWCI

0.00

Citation Percentile

0.2%

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.omton.2025.201078

publisherhttps://doi.org/10.1016/j.omton.2025.201078

publisherhttps://api.elsevier.com/content/article/PII:S295032992500147X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S295032992500147X?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41322199

Fields of Study

Signaling Pathways in DiseaseCancer-related gene regulationPeptidase Inhibition and Analysis

Keywords

Pancreatic cancerStromal cellCancerPIN1Cancer cellTherapeutic approachGastrointestinal cancerCancer-associated FibroblastsPdacMt: Regular IssueMolecular Crowbars

Pre-clinical evaluation of a potent and effective Pin1-degrading agent in pancreatic cancer

FAIR Checklist

Authors (10)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)